BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35395177)

  • 1. TIN2 deficiency leads to ALT-associated phenotypes and differentiation defects in embryonic stem cells.
    Yin S; Zhang F; Lin S; Chen W; Weng K; Liu D; Wang C; He Z; Chen Y; Ma W; Huang J; Huang Y; Songyang Z
    Stem Cell Reports; 2022 May; 17(5):1183-1197. PubMed ID: 35395177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).
    Falcinelli M; Dell'Omo G; Grassi E; Mariella E; Leto SM; Scardellato S; Lorenzato A; Arena S; Bertotti A; Trusolino L; Bardelli A; d'Adda di Fagagna F
    Cell Death Dis; 2023 Feb; 14(2):96. PubMed ID: 36759506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.
    Lovejoy CA; Takai K; Huh MS; Picketts DJ; de Lange T
    PLoS Biol; 2020 Jan; 18(1):e3000594. PubMed ID: 31895940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan nuclear receptors-induced ALT-associated PML bodies are targets for ALT inhibition.
    Gaela VM; Hsia HY; Joseph NA; Tzeng WY; Ting PC; Shen YL; Tsai CT; Boudier T; Chen LY
    Nucleic Acids Res; 2024 Jun; 52(11):6472-6489. PubMed ID: 38752489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
    Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
    Li F; Deng Z; Zhang L; Wu C; Jin Y; Hwang I; Vladimirova O; Xu L; Yang L; Lu B; Dheekollu J; Li JY; Feng H; Hu J; Vakoc CR; Ying H; Paik J; Lieberman PM; Zheng H
    EMBO J; 2019 Oct; 38(19):e96659. PubMed ID: 31454099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells.
    Chang FT; McGhie JD; Chan FL; Tang MC; Anderson MA; Mann JR; Andy Choo KH; Wong LH
    Nucleic Acids Res; 2013 Apr; 41(8):4447-58. PubMed ID: 23444137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
    Hu Y; Shi G; Zhang L; Li F; Jiang Y; Jiang S; Ma W; Zhao Y; Songyang Z; Huang J
    Sci Rep; 2016 Aug; 6():32280. PubMed ID: 27578458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA.
    Rose AM; Goncalves T; Cunniffe S; Geiller HEB; Kent T; Shepherd S; Ratnaweera M; O'Sullivan RJ; Gibbons RJ; Clynes D
    Nucleic Acids Res; 2023 Jul; 51(13):6509-6527. PubMed ID: 36940725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential nuclear ATRX expression in sarcomas.
    Koelsche C; Renner M; Johann P; Leiss I; Sahm F; Schimmack S; Wardelmann E; Renker EK; Schirmacher P; Korshunov A; von Deimling A; Mechtersheimer G
    Histopathology; 2016 Apr; 68(5):738-45. PubMed ID: 26291601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zscan4 Contributes to Telomere Maintenance in Telomerase-Deficient Late Generation Mouse ESCs and Human ALT Cancer Cells.
    Dan J; Zhou Z; Wang F; Wang H; Guo R; Keefe DL; Liu L
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
    Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
    Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells.
    Turkalo TK; Maffia A; Schabort JJ; Regalado SG; Bhakta M; Blanchette M; Spierings DCJ; Lansdorp PM; Hockemeyer D
    Nat Commun; 2023 Feb; 14(1):939. PubMed ID: 36805596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
    Kim JY; Brosnan-Cashman JA; An S; Kim SJ; Song KB; Kim MS; Kim MJ; Hwang DW; Meeker AK; Yu E; Kim SC; Hruban RH; Heaphy CM; Hong SM
    Clin Cancer Res; 2017 Mar; 23(6):1598-1606. PubMed ID: 27663587
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort.
    Ban X; Mo S; Lu Z; Jia C; Shao H; Yan J; Chang X; Mao X; Wu Y; Zhang Y; Fan X; Yu S; Chen J
    Neuroendocrinology; 2022; 112(5):510-522. PubMed ID: 34348341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of alternative lengthening of telomere markers in BRCA1 defective cells.
    Kargaran PK; Yasaei H; Anjomani-Virmouni S; Mangiapane G; Slijepcevic P
    Genes Chromosomes Cancer; 2016 Nov; 55(11):864-76. PubMed ID: 27295426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
    de Nonneville A; Salas S; Bertucci F; Sobinoff AP; Adélaïde J; Guille A; Finetti P; Noble JR; Churikov D; Chaffanet M; Lavit E; Pickett HA; Bouvier C; Birnbaum D; Reddel RR; Géli V
    EMBO Mol Med; 2022 Oct; 14(10):e15859. PubMed ID: 35920001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
    Voon HPJ; Collas P; Wong LH
    Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.